These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug standards laboratory enters second decade. Reese KM J Am Pharm Assoc; 1972 Jan; 12(1):16-20. PubMed ID: 5007258 [No Abstract] [Full Text] [Related]
23. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010). Schepers U; Wätzig H J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114 [TBL] [Abstract][Full Text] [Related]
24. Panel discussion: proposed changes in the USP--microbiological aspects. I. Proposed changes in the USP sterility test. Clapp FL Bull Parenter Drug Assoc; 1969; 23(6):252-4. PubMed ID: 4901566 [No Abstract] [Full Text] [Related]
25. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115 [No Abstract] [Full Text] [Related]
26. Standards for particulate matter in all parenteral drug products. Jeffrey LP; Pinkus TF Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053 [No Abstract] [Full Text] [Related]
28. USP and the development of drug standards. Banes D J Chem Inf Comput Sci; 1977 May; 17(2):95-6. PubMed ID: 853070 [No Abstract] [Full Text] [Related]
29. [Standardization as a basis planning and administration in drug industry and pharmacy (II)]. Wagler M Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874 [No Abstract] [Full Text] [Related]
30. Statistical characteristics of the USP content uniformity test. Pedersen AO; Torud Y Pharm Acta Helv; 1971 Feb; 46(2):114-20. PubMed ID: 5142661 [No Abstract] [Full Text] [Related]
31. Ingredients in pharmaceutical preparations: a problem not value. Lubner GC Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372 [No Abstract] [Full Text] [Related]
32. Information chapters in pharmacopoeias. Banes D Ann Ist Super Sanita; 1975; 11(3-4):290-5. PubMed ID: 1234730 [TBL] [Abstract][Full Text] [Related]
33. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities. Williams RL; ; J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277 [TBL] [Abstract][Full Text] [Related]
34. GMPs vs GCPs: United States Pharmacopeia General Chapters. Allen LV Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791 [No Abstract] [Full Text] [Related]
35. WHO expert committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser; 1984; 704():1-54. PubMed ID: 6437087 [No Abstract] [Full Text] [Related]
36. [Quality control in the pharmaceutical industry]. Bretscher E Pharm Acta Helv; 1972; 47(11):664-75. PubMed ID: 4657535 [No Abstract] [Full Text] [Related]
37. Drug product quality--views of the regulators. USP/NF: public standards for drug product quality. Grady LT J Am Pharm Assoc; 1976 Nov; 16(11):603-4. PubMed ID: 977885 [No Abstract] [Full Text] [Related]
38. What is a good drug? Owen JA Hosp Formul; 1975 Mar; 10(3):108. PubMed ID: 10316675 [No Abstract] [Full Text] [Related]
39. Pharmaceutical analysis: key to drug quality and control. Florey KG; Brewer GA Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421 [No Abstract] [Full Text] [Related]
40. FDA-USP drug product problem reporting program--an update. Wheatley LS Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]